GE HealthCare Technologies Inc. (GEHC) Stock Price & How to Invest

GE HealthCare is the medical technology business spun off from the former General Electric conglomerate as an independent company. It is one of the world's largest makers of medical imaging and diagnostic equipment. Its product portfolio spans MRI, CT, X-ray, ultrasound, and molecular imaging systems, plus contrast agents and radiopharmaceuticals used in scans, patient monitoring devices, and a growing suite of healthcare software and AI tools that help clinicians interpret images and manage care. GE HealthCare makes money by selling these large imaging systems to hospitals and clinics, and importantly through recurring revenue from service contracts, maintenance, software, and consumables like contrast media. With a large installed base of equipment worldwide, the company benefits from steady demand for diagnostics, an aging global population, and the growing role of AI in radiology. Headquartered in Chicago, it serves healthcare providers across developed and emerging markets and competes among the top global medical imaging vendors.

The financial profile is one of steady, mid-single-digit growth. Revenue rose from about $19.6 billion in 2023 to $20.6 billion in 2025 and stands near $21.3 billion over the trailing twelve months, with net income of about $2.0 billion, an operating margin near 15% and free cash flow of about $1.6 billion. 2026 has been uneven: Q1 revenue of about $5.1 billion came with EPS of $0.99, short of the $1.05 estimate, while Q2 revenue grew about 6% year over year and EPS of $1.13 beat the $1.04 consensus. In October the company received a CE mark for its MINItrace Magni cyclotron and expanded its PETtrace solid target platform to Copper-64, additions to its molecular imaging and radiopharmaceutical supply business.

The stock reflects that unevenness. At $70.33 on October 16, 2026, GEHC is down about 15% year to date and 4% over twelve months, well below its 52-week high of $89.77, though up about 13% over three months. BTIG lowered its price target to $75 from $79 on October 12. Q3 2026 results are scheduled for October 28, with consensus near $1.21 of EPS on about $5.35 billion of revenue.

GE HealthCare sells capital equipment to hospitals, whose budgets can tighten during economic or fiscal pressure, delaying purchases. It faces intense competition from Siemens Healthineers, Philips, and others, and pricing pressure in mature imaging categories. Supply chain disruptions and component shortages can affect deliveries. As a recently independent company, it carries debt from the spinoff (Yahoo shows about $10.5 billion of debt against $2.1 billion of cash) and must execute on its own strategy. Regulatory approval, reimbursement changes, and product recalls are risks in medical devices. Currency swings affect its global revenue. Margins in hardware can be modest, and growth depends on successfully expanding higher-margin software, services, and contrast media against capable, well-resourced competitors. Quarterly results have been uneven in 2026, with a Q1 EPS miss followed by a Q2 beat, and the stock is still about 15% lower year to date, so another miss could weigh on sentiment.

20 analysts publish price targets on GEHC, averaging $82.70 against a $69.57 price as of October 2026, or +18.9%. The published targets run from $70.00 to $96.00, a moderate spread, and the ratings split 16 buy, 5 hold, 0 sell. Over the last six months there have been 5 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full GEHC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on GE HealthCare Technologies Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Large installed base and recurring revenue. GE HealthCare has a vast installed base of imaging systems worldwide, generating recurring revenue from service contracts, maintenance, software, and consumables such as contrast agents. The most optimistic published target, $96.00, assumes this works close to its best case.

The case against. GE HealthCare sells capital equipment to hospitals, whose budgets can tighten during economic or fiscal pressure, delaying purchases. The most pessimistic target, $70.00, is roughly what GEHC is worth if this bites instead.

Read the full bull and bear case on GEHC, including what would have to change to break either one. Walnut is not an investment adviser.

No. GE HealthCare Technologies Inc. (GEHC) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see GE HealthCare Technologies Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$21.3 billion
• Revenue growth (Q2 2026, YoY): ~6%
• Operating margin: ~15%
• Net income (TTM): ~$2.0 billion
• EPS (Q2 2026 vs estimate): $1.13 vs $1.04
• P/E (trailing / forward): ~16x / ~13x
• Dividend yield: ~0.2% ($0.16 a year)
• Market cap: ~$32 billion

At about $70, GE HealthCare trades near 16x trailing and 13x forward earnings and about 11x EV/EBITDA, below where it stood at the start of 2026 after the shares fell about 15% year to date. Investors weigh steady diagnostics demand, recurring service revenue and AI-driven upgrades against hospital capital-spending cycles and spinoff debt. Q3 results on October 28 are expected to show EPS near $1.21; the 20-analyst mean target is about $83.

If you want GEHC exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to GEHC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get GEHC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (MOAT), which spreads the position across many companies. Or build it into a focused thematic portfolio, so GEHC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where GEHC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

GE HealthCare (GEHC) is a steady medical-imaging franchise whose recurring service and consumables revenue cushions hardware cyclicality, supported by aging-population diagnostics demand and AI-enabled imaging. In a portfolio it behaves as a defensive healthcare holding with moderate growth, carrying hospital capital-spending cycles and spinoff debt as its main risks. After a Q1 2026 earnings miss and a slide toward a 52-week low of $58.75, the stock has recovered about 13% over three months on a Q2 beat; it trades near 16x trailing and 13x forward earnings ahead of Q3 results on October 28.

Whether GEHC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is GEHC a buy or a sell?, and where the stock could go from here in the GEHC stock forecast.

For income investors, whether GEHC pays a dividend and how the payout looks is covered in does GEHC pay a dividend? And to weigh GEHC against a peer, read the full side-by-side comparisons: GEHC vs SIEGY and GEHC vs BAYRY.